583 Exploring the potential of T cell acute lymphoblastic leukemia (T-ALL) for generating leukemia-specific T cell responses that can be therapeutically harnessed with immunotherapy

• Andrew White,
• Andrew Weinberg,
• Todd Triplett,
• Sarah Church,
• Joshua Rios,
• Nisha Holay,
• Alexander Somma,
• Khrystyna North

Affiliations

Andrew White

6 Discipline of Ophthalmology, The University of Sydney, Sydney, New South Wales, Australia

Andrew Weinberg

Aff1 Earle A Chiles Cancer Research Institute/Providence Cancer Center Portland OR USA

Todd Triplett

1UT Dell Medical School, Austin, TX, USA

Sarah Church

Transitional Sciences, NanoString Technologies Inc, Seattle, Washington, USA

Joshua Rios

3St. Edward’s University, Austin, TX, USA

Nisha Holay

4University of Texas at Austin, austin, TX, USA

Alexander Somma

1University of Texas at Austin Dell Med, Austin, TX, USA

Khrystyna North

3NanoString, Seattle, WA, USA